Cargando…
Acute Myeloid Leukemia: A Concise Review
Acute myeloid leukemia (AML) is a heterogeneous clonal disorder characterized by immature myeloid cell proliferation and bone marrow failure. Cytogenetics and mutation testing remain a critical prognostic tool for post induction treatment. Despite rapid advances in the field including new drug targe...
Autores principales: | Saultz, Jennifer N., Garzon, Ramiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4810104/ https://www.ncbi.nlm.nih.gov/pubmed/26959069 http://dx.doi.org/10.3390/jcm5030033 |
Ejemplares similares
-
Clinical Applications of MicroRNAs in Acute Myeloid Leukemia: A Mini-Review
por: Bhatnagar, Bhavana, et al.
Publicado: (2021) -
The impact of COVID-19 on acute myeloid leukemia patients undergoing allogeneic stem cell transplantation: a concise review
por: Mansour, Reham Osama, et al.
Publicado: (2023) -
Concise Review: Chronic Myeloid Leukemia: Stem Cell Niche and Response to Pharmacologic Treatment
por: Arrigoni, Elena, et al.
Publicado: (2018) -
Comparison and validation of the 2022 European LeukemiaNet guidelines in acute myeloid leukemia
por: Lachowiez, Curtis A., et al.
Publicado: (2022) -
Non-Coding RNAs Are Implicit in Chronic Myeloid Leukemia Therapy Resistance
por: Rudich, Alexander, et al.
Publicado: (2022)